Niva Bupa Health Insurance Company Limited (BOM:544286)
India · Delayed Price · Currency is INR 79.98
-0.67 (-0.83%)
At close: Aug 8, 2025
Allakos Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
Premiums & Annuity Revenue | 60,419 | 58,399 | 44,179 | 26,628 | 17,525 | 11,509 | Upgrade |
Total Interest & Dividend Income | 5,114 | 4,665 | 2,970 | 1,862 | 1,228 | 863.99 | Upgrade |
Gain (Loss) on Sale of Investments | 92.8 | 92.8 | 111.08 | 49.4 | 262.54 | 60.4 | Upgrade |
Other Revenue | -676.32 | 145.78 | 36.93 | 3,641 | 2,677 | 1,724 | Upgrade |
Total Revenue | 64,949 | 63,302 | 47,297 | 32,180 | 21,693 | 14,157 | Upgrade |
Revenue Growth (YoY) | 39.20% | 33.84% | 46.98% | 48.35% | 53.23% | 35.77% | Upgrade |
Policy Benefits | 58,799 | 55,829 | 41,280 | 14,393 | 10,886 | 6,456 | Upgrade |
Policy Acquisition & Underwriting Costs | 318 | - | - | 1,908 | 1,204 | 634.81 | Upgrade |
Depreciation & Amortization | 206.93 | 206.93 | 282.25 | - | - | - | Upgrade |
Selling, General & Administrative | 1,675 | 1,894 | 1,745 | 11,842 | 8,598 | 5,454 | Upgrade |
Provision for Bad Debts | 12 | - | - | 10.25 | 221.71 | 283.45 | Upgrade |
Other Operating Expenses | -633.47 | 13.24 | 28.42 | 3,634 | 2,681 | 1,765 | Upgrade |
Total Operating Expenses | 62,542 | 60,177 | 45,516 | 31,787 | 23,591 | 14,592 | Upgrade |
Operating Income | 2,407 | 3,126 | 1,781 | 393.04 | -1,899 | -435.46 | Upgrade |
Interest Expense | -365.57 | -365.57 | -352.02 | -267.5 | -65.23 | -59.38 | Upgrade |
Currency Exchange Gain (Loss) | - | - | - | -0.14 | -1.27 | -2.54 | Upgrade |
Other Non Operating Income (Expenses) | -7.2 | - | - | - | 0.01 | -0 | Upgrade |
EBT Excluding Unusual Items | 2,034 | 2,760 | 1,429 | 125.4 | -1,965 | -497.39 | Upgrade |
Pretax Income | 2,034 | 2,760 | 1,429 | 125.4 | -1,965 | -497.39 | Upgrade |
Income Tax Expense | 731.19 | 731.19 | 365.75 | - | - | - | Upgrade |
Net Income | 1,303 | 2,029 | 1,064 | 125.4 | -1,965 | -497.39 | Upgrade |
Net Income to Common | 1,303 | 2,029 | 1,064 | 125.4 | -1,965 | -497.39 | Upgrade |
Net Income Growth | -3.66% | 90.78% | 748.12% | - | - | - | Upgrade |
Shares Outstanding (Basic) | 1,782 | 1,753 | 1,590 | 1,463 | 1,387 | 1,163 | Upgrade |
Shares Outstanding (Diluted) | 1,811 | 1,782 | 1,631 | 1,503 | 1,389 | 1,163 | Upgrade |
Shares Change (YoY) | 7.36% | 9.22% | 8.55% | 8.20% | 19.40% | 8.75% | Upgrade |
EPS (Basic) | 0.73 | 1.16 | 0.67 | 0.09 | -1.42 | -0.43 | Upgrade |
EPS (Diluted) | 0.72 | 1.14 | 0.65 | 0.08 | -1.42 | -0.43 | Upgrade |
EPS Growth | -10.01% | 75.39% | 712.50% | - | - | - | Upgrade |
Free Cash Flow | - | 16,336 | 7,969 | 5,547 | 3,090 | 2,287 | Upgrade |
Free Cash Flow Per Share | - | 9.17 | 4.88 | 3.69 | 2.23 | 1.97 | Upgrade |
Operating Margin | 3.71% | 4.94% | 3.77% | 1.22% | -8.75% | -3.08% | Upgrade |
Profit Margin | 2.01% | 3.21% | 2.25% | 0.39% | -9.06% | -3.51% | Upgrade |
Free Cash Flow Margin | - | 25.81% | 16.85% | 17.24% | 14.25% | 16.16% | Upgrade |
EBITDA | 2,701 | 3,396 | 2,015 | 485.93 | -1,810 | -214.93 | Upgrade |
EBITDA Margin | 4.16% | 5.37% | 4.26% | 1.51% | -8.34% | -1.52% | Upgrade |
D&A For EBITDA | 294.58 | 270.62 | 233.96 | 92.89 | 88.67 | 220.53 | Upgrade |
EBIT | 2,407 | 3,126 | 1,781 | 393.04 | -1,899 | -435.46 | Upgrade |
EBIT Margin | 3.71% | 4.94% | 3.77% | 1.22% | -8.75% | -3.08% | Upgrade |
Effective Tax Rate | 35.95% | 26.49% | 25.59% | - | - | - | Upgrade |
Updated Feb 17, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.